• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氨鲁米特药物性肾上腺切除术治疗晚期前列腺癌。

Aminoglutethimide medical adrenalectomy for advanced prostatic carcinoma.

作者信息

Sanford E J, Drago J R, Rohner T J, Santen R, Lipton A

出版信息

J Urol. 1976 Feb;115(2):170-4. doi: 10.1016/s0022-5347(17)59121-1.

DOI:10.1016/s0022-5347(17)59121-1
PMID:765499
Abstract

Complete adrenal suppression with aminoglutethimide has been accomplished in 7 patients with progressive stage D carcinoma of the prostate who had become refractory to orchiectomy and the administration of exogenous estrogens. A favorable response was noted in 3 patients. These preliminary results indicate that this agent may be as useful as surgical adrenalectomy in the treatment of progressive prostatic carcinoma. A brief discussion of the pharmacology of this agent, its mode of administration and the side effects are presented.

摘要

氨鲁米特已使7例前列腺D期进展性癌患者实现了完全肾上腺抑制,这些患者对睾丸切除术和外源性雌激素治疗已产生耐药。3例患者出现了良好反应。这些初步结果表明,该药物在治疗进展性前列腺癌方面可能与手术去肾上腺同样有效。本文简要讨论了该药物的药理学、给药方式及副作用。

相似文献

1
Aminoglutethimide medical adrenalectomy for advanced prostatic carcinoma.氨鲁米特药物性肾上腺切除术治疗晚期前列腺癌。
J Urol. 1976 Feb;115(2):170-4. doi: 10.1016/s0022-5347(17)59121-1.
2
Aminoglutethimide: medical adrenalectomy in the management of carcinoma of the prostate. A review after 6 years.氨鲁米特:药物性肾上腺切除术在前列腺癌治疗中的应用。6年回顾。
Br J Urol. 1980 Aug;52(4):328-9. doi: 10.1111/j.1464-410x.1980.tb08932.x.
3
Clinical effect of aminoglutethimide, medical adrenalectomy, in treatment of 43 patients with advanced prostatic carcinoma.氨鲁米特(药物性肾上腺切除术)治疗43例晚期前列腺癌的临床疗效。
Cancer. 1984 Apr 1;53(7):1447-50. doi: 10.1002/1097-0142(19840401)53:7<1447::aid-cncr2820530703>3.0.co;2-g.
4
Clinical and biochemical effect of aminoglutethimide in the treatment of advanced prostatic carcinoma.
J Urol. 1983 Jan;129(1):51-5. doi: 10.1016/s0022-5347(17)51916-3.
5
Aminoglutethimide: theoretical considerations and clinical results in advanced prostate cancer.氨鲁米特:晚期前列腺癌的理论思考与临床结果
Cancer Treat Res. 1988;39:83-96. doi: 10.1007/978-1-4613-1731-9_6.
6
Aminoglutethimide therapy for advanced carcinoma of the prostate.氨鲁米特治疗晚期前列腺癌
Br J Urol. 1982 Oct;54(5):552-5. doi: 10.1111/j.1464-410x.1982.tb13589.x.
7
Adrenal suppression in the treatment of carcinoma of the prostate.前列腺癌治疗中的肾上腺抑制
Br J Urol. 1974 Oct;46(5):555-9. doi: 10.1111/j.1464-410x.1974.tb03856.x.
8
Aminoglutethimide in advanced prostatic carcinoma.氨鲁米特治疗晚期前列腺癌
Br J Urol. 1987 Apr;59(4):323-7. doi: 10.1111/j.1464-410x.1987.tb04641.x.
9
Response to aminoglutethimide and cortisone acetate in advanced prostatic cancer.晚期前列腺癌对氨鲁米特和醋酸可的松的反应
Br J Cancer. 1984 Dec;50(6):757-63. doi: 10.1038/bjc.1984.253.
10
Letter: Medical adrenalectomy with aminoglutethimide.信函:用氨鲁米特进行肾上腺切除术
JAMA. 1975 Sep 8;233(10):1047-8. doi: 10.1001/jama.233.10.1047.

引用本文的文献

1
Precision medicine applications in prostate cancer.精准医学在前列腺癌中的应用。
Ther Adv Med Oncol. 2018 Jun 18;10:1758835918776920. doi: 10.1177/1758835918776920. eCollection 2018.
2
A history of prostate cancer treatment.前列腺癌治疗史。
Nat Rev Cancer. 2002 May;2(5):389-96. doi: 10.1038/nrc801.
3
Response to aminoglutethimide and cortisone acetate in advanced prostatic cancer.晚期前列腺癌对氨鲁米特和醋酸可的松的反应
Br J Cancer. 1984 Dec;50(6):757-63. doi: 10.1038/bjc.1984.253.
4
Mechanisms of action of aminoglutethimide as endocrine therapy of breast cancer.氨鲁米特作为乳腺癌内分泌治疗的作用机制
Drugs. 1988 Jun;35(6):685-710. doi: 10.2165/00003495-198835060-00005.
5
Hormonal aspects of prostatic cancer: a review.前列腺癌的激素方面:综述
J R Soc Med. 1985 Feb;78(2):129-35. doi: 10.1177/014107688507800212.
6
A phase II trial of carboplatin (NSC 241240) in advanced prostate cancer, refractory to hormonal therapy. An Eastern Cooperative Oncology Group pilot study.一项卡铂(NSC 241240)用于对激素治疗难治的晚期前列腺癌的II期试验。一项东部肿瘤协作组的试点研究。
Invest New Drugs. 1990;8 Suppl 1:S91-4. doi: 10.1007/BF00171992.
7
Drug therapy of prostatic cancer.前列腺癌的药物治疗
Drugs Aging. 1991 Sep-Oct;1(5):353-63. doi: 10.2165/00002512-199101050-00003.
8
Aromatase inhibitors in malignant diseases of aging.芳香化酶抑制剂在衰老相关恶性疾病中的应用
Drugs Aging. 1992 Nov-Dec;2(6):530-45. doi: 10.2165/00002512-199202060-00008.